Abstract
Abstract Preclinical safety studies of human subjects are an essential step in the drug development process. These studies provide valuable information for the investigational new drug (IND) application and the investigational drug brochure. This article focuses on the main issues related to preclinical studies of safety in human subjects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have